Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic

Dml Saunte; M Pereiro-Ferreirós; C Rodríguez-Cerdeira; A Y Sergeev; M Arabatzis; A Prohić; B M Piraccini; P Lecerf; P Nenoff; L P Kotrekhova; P P Bosshard; V Padovese; J C Szepietowski; B Sigurgeirsson; R J Nowicki; P Schmid-Grendelmeier; R J Hay

doi:10.1111/jdv.17241

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic

Dml Saunte
, M Pereiro-Ferreirós
, C Rodríguez-Cerdeira
, A Y Sergeev
, M Arabatzis
, A Prohić
, B M Piraccini
, P Lecerf
, P Nenoff
, L P Kotrekhova
, P P Bosshard
, V Padovese
, J C Szepietowski
, B Sigurgeirsson
, R J Nowicki
, P Schmid-Grendelmeier
, R J Hay

Dermatologisk Afdeling

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

BACKGROUND: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.

OBJECTIVES: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.

METHODS: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.

RESULTS: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.

CONCLUSIONS: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.

Originalsprog	Engelsk
Sider (fra-til)	1582-1586
Antal sider	5
Tidsskrift	Journal of the European Academy of Dermatology and Venereology : JEADV
Vol/bind	35
Udgave nummer	7
Tidlig onlinedato	25 mar. 2021
DOI	https://doi.org/10.1111/jdv.17241
Status	Udgivet - jul. 2021

Adgang til dokumentet

10.1111/jdv.17241

Citationsformater

Saunte, D., Pereiro-Ferreirós, M., Rodríguez-Cerdeira, C., Sergeev, A. Y., Arabatzis, M., Prohić, A., Piraccini, B. M., Lecerf, P., Nenoff, P., Kotrekhova, L. P., Bosshard, P. P., Padovese, V., Szepietowski, J. C., Sigurgeirsson, B., Nowicki, R. J., Schmid-Grendelmeier, P., & Hay, R. J. (2021). Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(7), 1582-1586. https://doi.org/10.1111/jdv.17241

@article{1da17613ec814050a200d87f0071db98,

title = "Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic",

abstract = "BACKGROUND: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.OBJECTIVES: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.METHODS: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.RESULTS: Representatives from 20 countries completed the questionnaires of which 17 (85 \%) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.CONCLUSIONS: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.",

author = "Dml Saunte and M Pereiro-Ferreir{\'o}s and C Rodr{\'i}guez-Cerdeira and Sergeev, \{A Y\} and M Arabatzis and A Prohi{\'c} and Piraccini, \{B M\} and P Lecerf and P Nenoff and Kotrekhova, \{L P\} and Bosshard, \{P P\} and V Padovese and Szepietowski, \{J C\} and B Sigurgeirsson and Nowicki, \{R J\} and P Schmid-Grendelmeier and Hay, \{R J\}",

note = "{\textcopyright} 2021 European Academy of Dermatology and Venereology.",

year = "2021",

month = jul,

doi = "10.1111/jdv.17241",

language = "English",

volume = "35",

pages = "1582--1586",

journal = "Journal of the European Academy of Dermatology and Venereology : JEADV",

issn = "0926-9959",

publisher = "John Wiley \& Sons Inc.",

number = "7",

}

Saunte, D, Pereiro-Ferreirós, M, Rodríguez-Cerdeira, C, Sergeev, AY, Arabatzis, M, Prohić, A, Piraccini, BM, Lecerf, P, Nenoff, P, Kotrekhova, LP, Bosshard, PP, Padovese, V, Szepietowski, JC, Sigurgeirsson, B, Nowicki, RJ, Schmid-Grendelmeier, P & Hay, RJ 2021, 'Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic', Journal of the European Academy of Dermatology and Venereology : JEADV, bind 35, nr. 7, s. 1582-1586. https://doi.org/10.1111/jdv.17241

TY - JOUR

T1 - Emerging antifungal treatment failure of dermatophytosis in Europe

T2 - take care or it may become endemic

AU - Saunte, Dml

AU - Pereiro-Ferreirós, M

AU - Rodríguez-Cerdeira, C

AU - Sergeev, A Y

AU - Arabatzis, M

AU - Prohić, A

AU - Piraccini, B M

AU - Lecerf, P

AU - Nenoff, P

AU - Kotrekhova, L P

AU - Bosshard, P P

AU - Padovese, V

AU - Szepietowski, J C

AU - Sigurgeirsson, B

AU - Nowicki, R J

AU - Schmid-Grendelmeier, P

AU - Hay, R J

PY - 2021/7

Y1 - 2021/7

N2 - BACKGROUND: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.OBJECTIVES: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.METHODS: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.RESULTS: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.CONCLUSIONS: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.

AB - BACKGROUND: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.OBJECTIVES: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.METHODS: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.RESULTS: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.CONCLUSIONS: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.

U2 - 10.1111/jdv.17241

DO - 10.1111/jdv.17241

M3 - Article

C2 - 33768571

SN - 0926-9959

VL - 35

SP - 1582

EP - 1586

JO - Journal of the European Academy of Dermatology and Venereology : JEADV

JF - Journal of the European Academy of Dermatology and Venereology : JEADV

IS - 7

ER -

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater